Chengzhou Lv

421 total citations
18 papers, 304 citations indexed

About

Chengzhou Lv is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery. According to data from OpenAlex, Chengzhou Lv has authored 18 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Chengzhou Lv's work include Thyroid Cancer Diagnosis and Treatment (9 papers), Thyroid and Parathyroid Surgery (6 papers) and Cancer-related molecular mechanisms research (5 papers). Chengzhou Lv is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (9 papers), Thyroid and Parathyroid Surgery (6 papers) and Cancer-related molecular mechanisms research (5 papers). Chengzhou Lv collaborates with scholars based in China and United States. Chengzhou Lv's co-authors include Wei Sun, Hao Zhang, Wenwu Dong, Jiapeng Huang, Zhihong Wang, Liang He, Xiaoyu Ji, Ping Zhang, Liang Shao and Dalin Zhang and has published in prestigious journals such as International Journal of Biological Macromolecules, Cell Death and Disease and Industrial Crops and Products.

In The Last Decade

Chengzhou Lv

15 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengzhou Lv China 9 213 147 67 48 30 18 304
Yanan Xu China 8 118 0.6× 86 0.6× 127 1.9× 75 1.6× 56 1.9× 14 287
Steffen Rump Germany 4 303 1.4× 227 1.5× 20 0.3× 29 0.6× 20 0.7× 8 420
Xin Yuan China 10 234 1.1× 189 1.3× 21 0.3× 24 0.5× 21 0.7× 22 302
Xingcheng Wu China 9 172 0.8× 169 1.1× 34 0.5× 56 1.2× 22 0.7× 24 285
Zhendong Xiang China 13 302 1.4× 265 1.8× 14 0.2× 26 0.5× 29 1.0× 15 395
Michał Świerniak Poland 7 218 1.0× 224 1.5× 85 1.3× 28 0.6× 18 0.6× 9 337
Shanghua Jing China 10 128 0.6× 86 0.6× 34 0.5× 25 0.5× 57 1.9× 23 214
Ling‐Yu Chu China 9 92 0.4× 64 0.4× 22 0.3× 75 1.6× 85 2.8× 30 220
Ziqin Liu China 9 192 0.9× 89 0.6× 13 0.2× 12 0.3× 46 1.5× 26 275

Countries citing papers authored by Chengzhou Lv

Since Specialization
Citations

This map shows the geographic impact of Chengzhou Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengzhou Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengzhou Lv more than expected).

Fields of papers citing papers by Chengzhou Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengzhou Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengzhou Lv. The network helps show where Chengzhou Lv may publish in the future.

Co-authorship network of co-authors of Chengzhou Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Chengzhou Lv. A scholar is included among the top collaborators of Chengzhou Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengzhou Lv. Chengzhou Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liu, Yan, Chengzhou Lv, Xiaomei Zhang, et al.. (2025). Plant-synthesized gold nanotheranostics for photothermal treatment and imaging of breast cancer: Harnessing flavonoids for dual-functionality. Industrial Crops and Products. 235. 121718–121718. 1 indexed citations
2.
Shi, Yang, et al.. (2025). pH-responsive carbohydrate polymer-based nanoparticles in cancer therapy. International Journal of Biological Macromolecules. 306(Pt 1). 141236–141236. 3 indexed citations
3.
Chen, Hao, Shuang Cai, Qu Li, et al.. (2025). Chitosan-based therapeutic approaches for gastrointestinal malignancies: A review of novel drug delivery platforms and theragnostic systems. Industrial Crops and Products. 235. 121608–121608.
4.
Lv, Chengzhou & Yulian Wu. (2025). Pathomics in Gastrointestinal Tumors: Research Progress and Clinical Applications. Cureus. 17(5). e85060–e85060.
5.
Lv, Chengzhou, et al.. (2024). Relative burden of cancer and noncancer mortality among long-term survivors of differentiated thyroid cancer in the US. Frontiers in Endocrinology. 15. 1425634–1425634.
6.
Ji, Xiaoyu, Chengzhou Lv, Jiapeng Huang, et al.. (2023). ALKBH5‐induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2. Cancer Science. 114(6). 2318–2334. 25 indexed citations
7.
Huang, Jiapeng, Jinyuan Shi, Wei Sun, et al.. (2023). Identification of a Novel Cuproptosis-Related Gene Signature and Integrative Analyses in Thyroid Cancer. Journal of Clinical Medicine. 12(5). 2014–2014. 8 indexed citations
8.
Wang, Zhihong, Wei Sun, Liang He, et al.. (2022). Incidental T1 stage medullary thyroid carcinoma: The effect of tumour diameter on prognosis and therapeutic implications. Clinical Endocrinology. 97(3). 355–362. 4 indexed citations
9.
Huang, Jiapeng, Wei Sun, Zhihong Wang, et al.. (2022). FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. Journal of Experimental & Clinical Cancer Research. 41(1). 42–42. 141 indexed citations
10.
Qin, Yuan, Wei Sun, Zhihong Wang, et al.. (2022). RBM47/SNHG5/FOXO3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma. Cell Death and Disease. 13(3). 270–270. 49 indexed citations
11.
Ji, Xiaoyu, Wei Sun, Chengzhou Lv, Jiapeng Huang, & Hao Zhang. (2022). Meta‐analysis of the efficacy and safety of thermal ablation for treating large benign thyroid nodules. Clinical Endocrinology. 97(5). 654–663. 5 indexed citations
12.
Zeng, Xue, Zhihong Wang, Wei Sun, et al.. (2021). High Incidence of Distant Metastasis Is Associated With Histopathological Subtype of Pediatric Papillary Thyroid Cancer - a Retrospective Analysis Based on SEER. Frontiers in Endocrinology. 12. 760901–760901. 10 indexed citations
13.
Lv, Chengzhou, Wei Sun, Jiapeng Huang, et al.. (2021). Expression Profiles of Circular RNAs in Human Papillary Thyroid Carcinoma Based on RNA Deep Sequencing. OncoTargets and Therapy. Volume 14. 3821–3832. 11 indexed citations
14.
Ji, Xiaoyu, Wei Sun, Chengzhou Lv, Jiapeng Huang, & Hao Zhang. (2021). Circular RNAs Regulate Glucose Metabolism in Cancer Cells. OncoTargets and Therapy. Volume 14. 4005–4021. 11 indexed citations
15.
Wang, Zhihong, Trevor E. Angell, Wei Sun, et al.. (2020). Analysis of the strategy of LT4 prescribing and TSH monitoring for thyroid carcinoma after lobectomy. Annals of Translational Medicine. 8(19). 1238–1238. 7 indexed citations
16.
Wang, Zhihong, Yuan Qin, Wei Sun, et al.. (2020). Unilateral Tnm T1 And T2 Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: Total Thyroidectomy or Lobectomy?. Endocrine Practice. 26(10). 1085–1092. 14 indexed citations
17.
Huang, Jiapeng, Wei Sun, Qingfu Zhang, et al.. (2020). Clinicopathological Characteristics and Prognosis of Poorly Differentiated Thyroid Carcinoma Diagnosed According to the Turin Criteria. Endocrine Practice. 27(5). 401–407. 6 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanan Xu Breakdown of academic impact, for papers by Steffen Rump Breakdown of academic impact, for papers by Xin Yuan Breakdown of academic impact, for papers by Xingcheng Wu Breakdown of academic impact, for papers by Zhendong Xiang Breakdown of academic impact, for papers by Michał Świerniak Breakdown of academic impact, for papers by Shanghua Jing Breakdown of academic impact, for papers by Ling‐Yu Chu Breakdown of academic impact, for papers by Ziqin Liu
Rankless by CCL
2026